Gregg Smith
Drug Development Advisor (Melbridge Therapeutics) at Synthesis Research
Based in Albert Park, Australia
7-day free trial · no credit card
Seniority
Other
Department
Other
Location
Albert Park
Industry
Biotechnology Research
Company size
4
Contact information
Reveal Gregg's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
g•••••••@synthesisres.com
Phone
5 credits+61 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Gregg Smith
Accomplished senior executive with over 20 years' international experience in the biotech/pharma industry. Instrumental in the development of momelotinib (OJJARA/OMJJARA) from initial IND filing through to its $1.9B sale to GSK. Extensive drug development experience, including leadership of 10+ preclinical and clinical programs, spanning from the discovery/development interface to Phase 1/2 clinical trials. Executive participation in multiple FDA regulatory interactions; Phase 3 study design and execution, and NDA preparation. Substantive expertise in corporate development and strategy. Lead/senior deal team member for M&A and licensing transactions totalling ~ US$3.5B. Therapeutic areas include haematology/oncology, inflammation, anti-infectives, neurology and pain.
Build a list of verified contacts at Synthesis Research
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Gregg
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime